We just published our first paper, “Cell-targeted vaccines: implications for adaptive immunity” in Frontiers in Immunology! 10.3389/fimmu.2023.1221008
Month: September 2023
Deak Lab wins NIH R56 Award
The Deak Laboratory was awarded an NIH R56 award entitled, “Generating Robust anti-HIV CD8 T cells using HIV-targeted Liposomal Vaccines” for one year totaling over $400,000. This award will provide preliminary data for our HIV targeted adjuvant project.